A second major healthcare organization in the United Kingdom has discontinued its relationship with an Israeli pharmaceutical company following sustained pressure from pro-Palestine advocates. The Royal College of Pharmacy announced that it is ending its partnership with Teva UK, the British subsidiary of global medicine producer Teva Pharmaceuticals. The decision removes the firm as both a sponsor and exhibitor from the college’s upcoming annual conference.
Royal College of Pharmacy Severs Ties With Israeli Pharma Firm Over Activist Pressure
Pressure from activists can shift corporate decisions. It shows how public sentiment influences institutional partnerships today.
This is a troubling precedent. Healthcare should remain neutral and focused on patient welfare, not political activism.